MENU
AKTS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aktis Oncology (AKTS) Earnings Date & Reports
Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies... Show more
Industry: #Telecommunications Equipment
A.I. Advisor
published Earnings
AKTS is expected to report earnings to rise 80.77% to -46 cents per share on November 12
Q3'26
Est.
$-0.47
Q1'24
Missed
by $0.14
Q4'23
Missed
by $0.03
Q3'23
Missed
by $0.09
Q2'23
Missed
by $0.04
The last earnings report on May 13 showed earnings per share of -25 cents, missing the estimate of -11 cents. With 97.61K shares outstanding, the current market capitalization sits at 932.18M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a manufacturer of filter products for radio frequency front-ends for mobile wireless devices
Industry Biotechnology
Industry
Telecommunications Equipment
Address
17 Drydock Avenue
Phone
+1 617 461-4023
Employees
75
Web
https://www.aktisoncology.com